Antigua and Barbuda vs Grenada: Hepatitis B surface antigen (HBsAg) prevalence
Antigua and Barbuda
0.2%
in 2024
Grenada
0.2%
in 2024
Antigua and Barbuda rank
82nd
Grenada rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Antigua and Barbuda
- Grenada
How they compare
Antigua and Barbuda currently reports 0.2% against 0.2% in Grenada, a difference of 0.0%.
Across all 10 years both countries report, Grenada has been ahead every year.
Antigua and Barbuda ranks 82nd and Grenada ranks 82nd of 194 countries.
Head to head by decade
| Decade | Antigua and Barbuda | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Antigua and Barbuda or Grenada?
- Antigua and Barbuda, at 0.2% against 0.2% in Grenada as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Antigua and Barbuda and Grenada?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Grenada?
- 10 years are reported by both, from 2015 to 2024.
- How do Antigua and Barbuda and Grenada rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Antigua and Barbuda ranks 82nd and Grenada ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.